Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
Expert Opinion in Pharmacotherapy, 07/01/09
Iacobellis A et al. - Treatment is only recommended for a well-compensated liver cirrhosis, whereas antiviral therapy is commonly not implemented in cirrhotics with signs of liver decompensation, over the concern that the use of peginterferon and ribavirin might expose patients to severe treatment-related side effects. This review focuses on data available to support both efficacy and safety of antiviral therapy in both compensated and decompensated cirrhotic patients.
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09
Drugs for preventing malaria in travellers
Cochrane Reviews, 10/23/09
Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/21/09
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09
Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients
Clinical Infectious Diseases, 10/16/09
Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study
Indian Journal of Nephrology, 10/16/09
Article Search
Sponsor


See Latest Articles


